JPS52125620A - Production of hydrophobic vaccine - Google Patents

Production of hydrophobic vaccine

Info

Publication number
JPS52125620A
JPS52125620A JP4212977A JP4212977A JPS52125620A JP S52125620 A JPS52125620 A JP S52125620A JP 4212977 A JP4212977 A JP 4212977A JP 4212977 A JP4212977 A JP 4212977A JP S52125620 A JPS52125620 A JP S52125620A
Authority
JP
Japan
Prior art keywords
production
vaccine
hydrophobic
hydrophobic vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP4212977A
Other languages
English (en)
Other versions
JPH021807B2 (ja
Inventor
Baruto Rudorufu
Ieegaa Osukaru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of JPS52125620A publication Critical patent/JPS52125620A/ja
Publication of JPH021807B2 publication Critical patent/JPH021807B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP4212977A 1976-04-14 1977-04-14 Production of hydrophobic vaccine Granted JPS52125620A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2616407A DE2616407C3 (de) 1976-04-14 1976-04-14 Verfahren zur Herstellung eines Tollwut-Impfstoffs

Publications (2)

Publication Number Publication Date
JPS52125620A true JPS52125620A (en) 1977-10-21
JPH021807B2 JPH021807B2 (ja) 1990-01-12

Family

ID=5975368

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4212977A Granted JPS52125620A (en) 1976-04-14 1977-04-14 Production of hydrophobic vaccine

Country Status (16)

Country Link
US (1) US4115195A (ja)
JP (1) JPS52125620A (ja)
AT (1) AT362496B (ja)
BE (1) BE853604A (ja)
CA (1) CA1092973A (ja)
DE (1) DE2616407C3 (ja)
DK (1) DK162977A (ja)
ES (1) ES457600A1 (ja)
FR (1) FR2347933A1 (ja)
GB (1) GB1565453A (ja)
IE (1) IE44815B1 (ja)
IL (1) IL51864A (ja)
IT (1) IT1075693B (ja)
LU (1) LU77110A1 (ja)
MX (1) MX4221E (ja)
NL (1) NL188206C (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH638985A5 (de) * 1979-04-10 1983-10-31 Schweiz Serum & Impfinst Verfahren zur herstellung eines tollwutimpfstoffes und danach erhaltener impfstoff.
US4584194A (en) * 1980-07-30 1986-04-22 Norden Laboratories, Inc. Inactivated rabies vaccine for veterinary use
US4347239A (en) * 1980-07-30 1982-08-31 Norden Laboratories, Inc. Inactivated rabies vaccine for veterinary use
US4726946A (en) * 1980-07-30 1988-02-23 Norden Laboratories, Inc. Inactivated rabies vaccine for veterinary use
US4711778A (en) * 1980-07-30 1987-12-08 Norden Laboratories, Inc. Inactivated rabies vaccine for veterinary use
US4429045A (en) 1980-07-30 1984-01-31 Norden Laboratories, Inc. Rabies virus adapted for growth in swine testicle cell culture
JPS6147187A (ja) * 1984-08-10 1986-03-07 Chemo Sero Therapeut Res Inst 狂犬病ウイルスの精製方法
JPH02247633A (ja) * 1989-03-20 1990-10-03 Ricoh Co Ltd 複写機用露光装置
ZA9710606B (en) * 1996-12-05 1998-06-12 Akzo Nobel Nv Non-virulent Mycoplasma synoviae vaccine thereof.
US8361776B2 (en) * 2007-07-03 2013-01-29 Cadila Healthcare Limited Adaptation of Pitman Moore strain of rabies virus to primary chick embryo fibroblast cell cultures
CN103100083A (zh) * 2011-11-10 2013-05-15 北京佰康安生物科技有限公司 疫苗及其制备方法
CN103865888B (zh) * 2014-04-03 2016-03-23 深圳市卫光生物制品股份有限公司 狂犬病病毒ctn-1株对原代鸡胚成纤维细胞的适应方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2768114A (en) * 1953-08-21 1956-10-23 American Cyanamid Co Rabies vaccines and methods of preparing the same

Also Published As

Publication number Publication date
NL188206C (nl) 1992-05-06
DE2616407A1 (de) 1977-10-20
BE853604A (fr) 1977-10-14
IL51864A (en) 1980-05-30
NL7703880A (nl) 1977-10-18
DE2616407C3 (de) 1980-02-21
JPH021807B2 (ja) 1990-01-12
US4115195A (en) 1978-09-19
IE44815B1 (en) 1982-04-07
ATA257177A (de) 1980-10-15
CA1092973A (en) 1981-01-06
AT362496B (de) 1981-05-25
IT1075693B (it) 1985-04-22
GB1565453A (en) 1980-04-23
DE2616407B2 (ja) 1979-06-21
LU77110A1 (ja) 1977-11-14
IL51864A0 (en) 1977-06-30
FR2347933A1 (fr) 1977-11-10
FR2347933B1 (ja) 1980-03-07
MX4221E (es) 1982-02-16
DK162977A (da) 1977-10-15
ES457600A1 (es) 1978-01-16
IE44815L (en) 1977-10-14
NL188206B (nl) 1991-12-02

Similar Documents

Publication Publication Date Title
GB1549963A (en) Production of light-conductor structures
JPS5332164A (en) Production of icecreams
JPS5323994A (en) Production of 33chlorcephlosporin
JPS52125620A (en) Production of hydrophobic vaccine
JPS5436268A (en) Production of gammaapyrones
JPS5356654A (en) Production of dichloroazetidinone
JPS5340735A (en) Production of pentaapeptide
JPS6427487A (en) Production of 1-desoxynodirimycin
GB1533200A (en) Production of methyldichlorophosphane
JPS535194A (en) Improved production of betaalactam
JPS5311746A (en) Production of artificial chippwood
IL53038A (en) Preparation of certain nuclear-chlorinated benzotrichlorides
JPS535151A (en) Production of 11alphaa hydroxycholestelol
JPS537676A (en) Production of 6a*10aaciss hexahydrobenzopyranones
GB1549911A (en) Production of light-conductor structures
JPS5331653A (en) Production of betaa methylgigoxine
JPS52108974A (en) Production of triazolethiol
JPS5372896A (en) Production of polylisine
JPS52105242A (en) Production of instant sekihan
IL52194A0 (en) Production of o o-dialkyl-phosphorochloridothionates
JPS52117494A (en) Production of antiiulcer substance
JPS5369877A (en) Production of fixed glucoseisomerase
JPS5287257A (en) Production of sekihan
JPS5344571A (en) Production of benzisoquinolinediones
JPS5332165A (en) Production of icecake